Advice for New Nurse Practitioners Working With Patients With Endometrial Cancer
Closing their discussion, the panel shares advice for new nurse practitioners caring for patients who have endometrial cancer.
Greatest Unmet Needs for Patients with Endometrial Cancer
The panel shares the most critical unmet needs for patients with endometrial cancer.
Discussing Dose Reductions and Interruptions with Patients on Therapy for Endometrial Cancer
Kimberly A. Spickes, CNP, discusses how often patients with endometrial cancer have dose reductions or interruptions at her institution, and who is involved in the decision to dose-reduce.
Proactive Adverse Effect Management for Patients on Therapy for Endometrial Cancer
Nurse Practitioner Kimberly Halla explains the proactive measures she takes to ensure patients with endometrial cancer are prepared to experience and manage the adverse effects of treatment.
Adverse Events Seen With Combination Lenvatinib and Pembrolizumab for Recurrent Endometrial Cancer
Kimberly A. Spickes, CNP, details the adverse events she sees with combination lenvatinib and pembrolizumab treatment for recurrent endometrial cancer.
Monitoring Patients on Therapy for Recurrent Endometrial Cancer
Kimberly Halla, NP, describes the standards for monitoring patients on therapy for recurrent endometrial cancer, including how often patients are seen in-person.
Educating Patients With Endometrial Cancer on Treatment-Related Adverse Events
The panel explains how to educate patients on the adverse effects they may experience with chemotherapy, their options for management, and the importance of encouraging patients to contact their care team.
Treatment Options for Patients with Recurrent Endometrial Cancer
The panel reviews the second-line treatment options for patients with recurrent endometrial cancer.
Efficacy of Chemotherapy in Patients with Advanced Endometrial Cancer
Nurse Practitioner Kathleen Lutz talks about the efficacy of chemotherapy in patients with endometrial cancer, and how she discusses the chance of disease recurrence with patients.
Common Adverse Events Seen With Chemotherapy for Advanced Endometrial Cancer
Continuing her discussion, Kathleen highlights the most common adverse events she sees in patients treated with chemotherapy for advanced endometrial cancer who are unfit for surgery.
First-Line Treatments for Patients With Advanced Endometrial Cancer Who Are Unfit for Surgery
Kathleen Lutz, RN, NP-BC WH, explains the most commonly used first-line treatment options in patients with advanced endometrial cancer who are unsuitable candidates for surgery.
Currently Available Treatment Modalities in Endometrial Cancer
The panel reviews the current treatment modalities for endometrial cancer and in what circumstances each is considered for a patient.
Fertility and Other Treatment Considerations for Patients With Advanced Endometrial Cancer
The panel shares how they determine a treatment regimen for patients with advanced endometrial cancer taking into consideration fertility and family planning, hereditary conditions, and comorbidities.
Patient Profile Presentation: A 76-Year-Old Woman With Advanced Endometrial Cancer
Kathleen Lutz, RN, NP-BC WH, presents a 76-year-old woman with advanced endometrial cancer, and the panel assesses the chosen treatment regimens.
Second-Line Treatment of R/R LBCL With Lisocabtagene Maraleucel (Liso-cel)
ZUMA-7: Axicabtagene Ciloleucel as a Second-Line Therapy for LBCL
Currently Available Treatment Options for Patients With R/R DLBCL
Overview of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
2 Clarke Drive Cranbury, NJ 08512